2004, Number 2
<< Back
Acta Med 2004; 2 (2)
Iatrogenic Cancer: Obstacles and Possibilities in Gene Therapy
Castañeda M
Language: Spanish
References: 6
Page: 133-136
PDF size: 69.54 Kb.
Text Extraction
No abstract
REFERENCES
Castañeda M. Antología de Biología Molecular. 2a edición, México, DF: Dirección General de Publicaciones, UNAM; 1985: 41-58.
Kohn DB, Weinberg KI, Nolta JA, Lenarsky C et al. Engraftment of gene-modified umbilical cord cells in neonates with adenosine deaminase deficiency. Nat Med 1995; 1: 1017-1023.
Hacein-Bey-Abina S, LeDeist F, Carlie F, Bouneaud C et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
Aiuti A, Slavin S, Aker M, Ficara F et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410-2413.
Hacein-Bey-Abina S, vonKalle C, Schmidt M, LeDeist F et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255-256.
Wu X, Li Y, Crise B y Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751.
Full text